An effective vaccine against Chikungunya- a viral disease characterized by high fever, lasting between seven to 10 days with excruciating pain in the joints for over three months, has been found. India has been seeing explosive outbreaks of this mosquito-borne disease which came to the country in 2006 after a gap of 32 years.
Researchers from the University of Texas, Colorado, the University of Wisconsin, the Centers for Disease Control and Prevention and the University of Alabama have successfully created a new experimental vaccine against the Chikungunya virus.
A single dose of the experimental vaccine protected lab mice from infection with the virus, according to a paper published online in the journal PLoS Pathogens. Currently, there is no treatment or vaccine for Chikungunya and it has to be tackled with paracetamol and fluids.
The experimental vaccine, which is expected to go into human trials in the next two years, is a recombinant live-attenuated vaccine created by genetically modifying the Chikungunya virus.
For More Updates, follow us on 
and 